Search Results - F. Thistlethwaite

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome by S. Chow, V. Galvis, M. Pillai, R. Leach, E. Keene, A. Spencer-Shaw, A. Shablak, J. Shanks, T. Liptrot, F. Thistlethwaite, R. E. Hawkins

    Published in Journal for ImmunoTherapy of Cancer (2016-11-01)
    Get full text
    Article


  2. 2

    Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial by K.S. Shohdy, M. Pillai, K.S. Abbas, J. Allison, T. Waddell, E. Darlington, S. Mohammad, S. Hood, S. Atkinson, K. Simpson, D. Morgan, P. Nathan, E. Kilgour, C. Dive, F. Thistlethwaite

    Published in Immuno-Oncology and Technology (2024-06-01)
    Get full text
    Article


Search Tools: